The cytokine milieu of diabetic wounds

@article{Declue2015TheCM,
  title={The cytokine milieu of diabetic wounds},
  author={Cory Declue and Laurie P Shornick},
  journal={Diabetes management},
  year={2015},
  volume={5},
  pages={525-537}
}
Nonhealing diabetic foot ulcers are a significant complication of diabetes. They develop due to peripheral neuropathy, and may take weeks or months to close. A failure to heal may necessitate lower limb amputation causing significant morbidity and mortality. Wound healing impairment in diabetic patients is associated with delays in immune cell migration and altered macrophage activation. These processes are orchestrated by the cytokine milieu in the wound manifested by an upregulation of… 

Figures from this paper

Improving Dietary Intake of Essential Nutrients Can Ameliorate Inflammation in Patients with Diabetic Foot Ulcers

The positive effects of nutritional intervention on controlling inflammation in DFU patients were showed and more clinical trials with a larger population and longer duration of time are needed to confirm these results.

Improvement of diabetic wound healing by topical application of Vicenin-2 hydrocolloid film on Sprague Dawley rats

Data suggests that the VCN-2 film facilitated healing in hyperglycemic conditions by releasing growth factors such as (VEGF and TGF-β) to enhance cell proliferation, migration, and wound contraction via the VEGF and T GF-β mechanism pathways.

BACTERIAL PROFILE IN PATIENTS WITH DIABETIC FOOT INFECTIONS AND ITS ASSOCIATION WITH TNF- α

Bacterial pathogens showed resistance to nearly all of the antibiotics in this study, and Imipenem was the most efficient antibiotics against tested isolates.

Lupeol, a Dietary Triterpene, Enhances Wound Healing in Streptozotocin-Induced Hyperglycemic Rats with Modulatory Effects on Inflammation, Oxidative Stress, and Angiogenesis

The findings indicate that lupeol possesses wound healing potential in hyperglycemic conditions and may be useful as a treatment for chronic wounds in diabetic patients.

Dermal fibroblasts cultured from donors with type 2 diabetes mellitus retain an epigenetic memory associated with poor wound healing responses

Data demonstrate that T2DM-DF exhibit a selective loss of responsiveness to TNF-α, particularly regarding proliferative and secretory functions, that may explain the susceptibility to chronic wounds in patients with Type 2 diabetes mellitus.

The expression of TNF-α, IL-1β, and IL-10 in the diabetes mellitus condition induced by the combination of spirulina and chitosan

The combination of 12% spirulina and 20% chitosan can accelerate wound healing through its intervention in cytokines IL-1β, TNF-α and IL-10, which are two natural substances that have been proven to have anti-inflammatory properties.

The effect of rheopheresis treatment on the cytokine profile in diabetic foot syndrome with hyperviscosity in the aspect of clinical changes: A preliminary study.

Application of rheopheresis in patients with diabetic foot syndrome has a beneficial effect, providing favorable rheological condition, normalizing cytokine profile and reducing the sensorineural symptoms.

Early and Intensive Glycemic Control for Diabetic Foot Ulcer Healing: A Prospective Observational Nested Cohort Study.

Early and intensive glycemic control in the first 4 weeks of treatment initiation is associated with greater healing of DFU independent of initial ulcer area, and Cox-regression analysis revealed lower baseline ulcers area significantly predicted DFU healing by 12 weeks.

References

SHOWING 1-10 OF 122 REFERENCES

Cellular and molecular basis of wound healing in diabetes.

In this issue of the JCI, Gallagher and colleagues demonstrate that in diabetic mice, hyperoxia enhances the mobilization of circulating endothelial progenitor cells (EPCs) from the bone marrow to the peripheral circulation, resulting in accelerated wound healing.

Chemokines and Diabetic Wound Healing

The potential roles of chemokines and inflammatory or immune cells in nonhealing diabetic wounds, including impairments in growth factor expression, angiogenesis, extracellular matrix formation, and reepithelialization, are examined.

Agent‐based model of inflammation and wound healing: insights into diabetic foot ulcer pathology and the role of transforming growth factor‐β1

An agent‐based model capable of reproducing qualitatively much of the literature data on skin wound healing, including changes in relevant cell populations and their key effector cytokines, is developed and found that these therapies would have similar effects regardless of the initial assumption of the derangement that underlies DFU.

Immune Mediators in Patients With Acute Diabetic Foot Syndrome

It is demonstrated in this cross-sectional study that acute foot ulcers and their severity are associated with a marked upregulation of acute-phase proteins, cytokines, and chemokines independently of the concomitant infection.

Treatment of diabetic mice with undenatured whey protein accelerates the wound healing process by enhancing the expression of MIP-1α, MIP-2, KC, CX3CL1 and TGF-β in wounded tissue

Compared with untreated diabetic mice, supplementation with WP significantly accelerated the closure of diabetic wounds by limiting inflammatory stimuli via the restoration of normal IL-10, TNF-α, IL-1β and IL-6 levels.

Macrophage Dysfunction Impairs Resolution of Inflammation in the Wounds of Diabetic Mice

First evidence is presented demonstrating that diabetic wounds suffer from dysfunctional macrophage efferocytosis resulting in increased apoptotic cell burden at the wound site, which prolongs the inflammatory phase and complicates wound healing.

Momordica charantia ointment accelerates diabetic wound healing and enhances transforming growth factor-β expression.

MC ointment has a promising potential for use as an alternative topical medication for diabetic wounds because it accelerates wound healing in diabetic rats, and it is suggested here that this occurs by enhancing TGF-β expression.

Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing.

Administration of exogenous SDF-1alpha into wounds reversed the EPC homing impairment and, with hyperoxia, synergistically enhanced EPC mobilization, homing, neovascularization, and wound healing.
...